Showing results (621-630 of 667) with videos related to

Sort By:
Pageof 67
Blood|February 22, 2022
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemiaShunsuke Kimura, Lindsey Montefiori, Ilaria Iacobucci, et al.
Blood Advances|April 21, 2022
Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALLAimee C Talleur, Amr Qudeimat, Jean-Yves Métais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2024
Genomic Determinants of Outcome in Acute Lymphoblastic LeukemiaTi-Cheng Chang, Wenan Chen, Chunxu Qu, et al.
Pediatric Blood & Cancer|December 31, 2013
Asociación de Hemato-Oncología Pediátrica de Centro América (AHOPCA): a model for sustainable development in pediatric oncologyRonald D Barr, Federico Antillón Klussmann, Fulgencio Baez, et al.
The Lancet. Oncology|May 5, 2018
The My Child Matters programme: effect of public-private partnerships on paediatric cancer care in low-income and middle-income countriesScott C Howard, Alia Zaidi, Xueyuan Cao, et al.
JAMA|June 28, 2012
Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphomaMonika L Metzger, Howard J Weinstein, Melissa M Hudson, et al.
Cancer|December 20, 2022
Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemiaChih-Hsiang Yu, Shiann-Tarng Jou, Ying-Hui Su, et al.
Cancer Cell|April 24, 2018
Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic LeukemiaMichelle L Churchman, Maoxiang Qian, Geertruy Te Kronnie, et al.
Blood|November 14, 2013
Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study groupTrudy D Buitenkamp, Shai Izraeli, Martin Zimmermann, et al.
Lancet (London, England)|November 19, 2015
Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd editionHellen Gelband, Rengaswamy Sankaranarayanan, Cindy L Gauvreau, et al.
Pageof 67